The costamere bridges sarcomeres to the sarcolemma in striated muscle

Progress in Pediatric Cardiology

Volumn 31, Issue 2, 2011, Pages 83-88

  Peter, Angela K ^a   Cheng, Hongqiang ^a   Ross, Robert S ^a,b   Knowlton, Kirk U ^a   Chen, Ju ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Costamere; Cypher ZASP; Integrin; Mechanotransduction; Vinculin; Z line

Indexed keywords

CELL PROTEIN; CONNECTIN; DYSTROPHIN GLYCOPROTEIN COMPLEX; ENH CYPHER CALSARCIN PROTEIN COMPLEX; INTEGRIN VINCULIN TALIN PROTEIN COMPLEX; UNCLASSIFIED DRUG;

ARTICLE; CARDIOMYOPATHY; CELL FUNCTION; CELL ORGANELLE; COSTAMERE; GENE MUTATION; HUMAN; MUSCLE Z BAND; MYOFILAMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RISK FACTOR; SARCOLEMMA; SARCOMERE; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; THIN FILAMENT;

EID: 79955482215     PISSN: 10589813     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ppedcard.2011.02.003     Document Type: Article

References (97)

1. Bloch R.J., Gonzalez-Serratos H. Lateral force transmission across costameres in skeletal muscle. Exerc Sport Sci Rev 2003, 31(2):73-78.
2. Hoshijima M. Mechanical stress-strain sensors embedded in cardiac cytoskeleton: Z disk, titin, and associated structures. Am J Physiol Heart Circ Physiol 2006, 290(4):H1313-H1325.
3. Russell B., Curtis M.W., Koshman Y.E., Samarel A.M. Mechanical stress-induced sarcomere assembly for cardiac muscle growth in length and width. J Mol Cell Cardiol 2010, 48(5):817-823.
4. Frank D., Kuhn C., Katus H.A., Frey N. Role of the sarcomeric Z-disc in the pathogenesis of cardiomyopathy. Future Cardiol 2007, 3(6):611-622.
5. Selcen D., Carpen O. The Z-disk diseases. Adv Exp Med Biol 2008, 642:116-130.
6. Clark K.A., McElhinny A.S., Beckerle M.C., Gregorio C.C. Striated muscle cytoarchitecture: an intricate web of form and function. Annu Rev Cell Dev Biol 2002, 18:637-706.
7. Morimoto S. Sarcomeric proteins and inherited cardiomyopathies. Cardiovasc Res 2008, 77(4):659-666.
8. Bowles N.E., Bowles K., Towbin J.A. Prospects for gene therapy for inherited cardiomyopathies. Prog Pediatr Cardiol 2000, 12(1):133-145.
9. Marian A.J. Hypertrophic cardiomyopathy: from genetics to treatment. Eur J Clin Invest 2010, 40(4):360-369.
10. Ottenheijm C.A., Heunks L.M., Dekhuijzen R.P. Diaphragm adaptations in patients with COPD. Respir Res 2008, 9:12.
11. Sanger J.M., Sanger J.W. The dynamic Z bands of striated muscle cells. Sci Signal 2008, 1(32):pe37.
12. Goldstein M.A., Schroeter J.P., Michael L.H. Role of the Z band in the mechanical properties of the heart. FASEB J 1991, 5(8):2167-2174.
13. Bang M.L., Li X., Littlefield R., et al. Nebulin-deficient mice exhibit shorter thin filament lengths and reduced contractile function in skeletal muscle. J Cell Biol 2006, 173(6):905-916.
14. Kruger M., Linke W.A. Titin-based mechanical signalling in normal and failing myocardium. J Mol Cell Cardiol 2009, 46(4):490-498.
15. Luther P.K. The vertebrate muscle Z-disc: sarcomere anchor for structure and signalling. J Muscle Res Cell Motil 2009, 30(5-6):171-185.
16. Ervasti J.M. Costameres: the Achilles' heel of Herculean muscle. J Biol Chem 2003, 278(16):13591-13594.
17. Sheikh F., Bang M.L., Lange S., Chen J. "Z"eroing in on the role of Cypher in striated muscle function, signaling, and human disease. Trends Cardiovasc Med 2007, 17(8):258-262.
18. Chen J., Chien K.R. Complexity in simplicity: monogenic disorders and complex cardiomyopathies. J Clin Invest 1999, 103(11):1483-1485.
19. Zheng M., Cheng H., Banerjee I., Chen J. ALP/Enigma PDZ-LIM domain proteins in the heart. J Mol Cell Biol 2010, 2(2):96-102.
20. Zhou Q., Ruiz-Lozano P., Martone M.E., Chen J. Cypher, a striated muscle-restricted PDZ and LIM domain-containing protein, binds to alpha-actinin-2 and protein kinase C. J Biol Chem 1999, 274(28):19807-19813.
21. Huang C.Q., Zhou Q., Liang P.H., et al. Characterization and in vivo functional analysis of splice variants of cypher. J Biol Chem 2003, 278(9):7360-7365.
22. Zheng M., Cheng H., Li X., et al. Cardiac-specific ablation of Cypher leads to a severe form of dilated cardiomyopathy with premature death. Hum Mol Genet 2009, 18(4):701-713.
23. von Nandelstadh P., Ismail M., Gardin C., et al. A class III PDZ binding motif in the myotilin and FATZ families binds enigma family proteins: a common link for Z-Disc myopathies. Mol Cell Biol 2009, 29(3):822-834.
24. Zhou Q., Chu P.H., Huang C., et al. Ablation of cypher, a PDZ-LIM domain Z-line protein, causes a severe form of congenital myopathy. J Cell Biol 2001, 155(4):605-612.
25. Arimura T., Hayashi T., Terada H., et al. A Cypher/ZASP mutation associated with dilated cardiomyopathy alters the binding affinity to protein kinase C. J Biol Chem 2004, 279(8):6746-6752.
26. Vatta M., Mohapatra B., Jimenez S., et al. Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction. J Am Coll Cardiol 2003, 42(11):2014-2027.
27. Moric-Janiszewska E., Markiewicz-Loskot G. Genetic heterogeneity of left-ventricular noncompaction cardiomyopathy. Clin Cardiol 2008, 31(5):201-204.
28. Xing Y., Ichida F., Matsuoka T., et al. Genetic analysis in patients with left ventricular noncompaction and evidence for genetic heterogeneity. Mol Genet Metab 2006, 88(1):71-77.
29. Zheng M., Cheng H., Banerjee I., Chen J. ALP/Enigma PDZ-LIM domain proteins in the heart. J Mol Cell Biol 2010, 2(2):96-102.
30. Griggs R., Vihola A., Hackman P., et al. Zaspopathy in a large classic late-onset distal myopathy family. Brain 2007, 130:1477-1484.
31. Nakagawa N., Hoshijima M., Oyasu M., et al. ENH, containing PDZ and LIM domains, heart/skeletal muscle-specific protein, associates with cytoskeletal proteins through the PDZ domain. Biochem Biophys Res Commun 2000, 272(2):505-512.
32. Ueki N., Seki N., Yano K., et al. Isolation, tissue expression, and chromosomal assignment of a human LIM protein gene, showing homology to rat Enigma homologue (ENH). J Hum Genet 1999, 44(4):256-260.
33. Niederlander N., Fayein N.A., Auffray C., Pomies P. Characterization of a new human isoform of the enigma homolog family specifically expressed in skeletal muscle. Biochem Biophys Res Commun 2004, 325(4):1304-1311.
34. Cheng H., Kimura K., Peter A.K., et al. Loss of enigma homolog protein results in dilated cardiomyopathy. Circ Res 2010, 107(3):348-356.
35. Wang X., Su H. Unraveling enigma in the z-disks. Circ Res 2010, 107(3):321-323.
36. Pardo J.V., Siliciano J.D., Craig S.W. A vinculin-containing cortical lattice in skeletal muscle: transverse lattice elements ("costameres") mark sites of attachment between myofibrils and sarcolemma. Proc Natl Acad Sci USA 1983, 80(4):1008-1012.
37. Mansour H., de Tombe P.P., Samarel A.M., Russell B. Restoration of resting sarcomere length after uniaxial static strain is regulated by protein kinase Cepsilon and focal adhesion kinase. Circ Res 2004, 94(5):642-649.
38. Danowski B.A., Imanaka-Yoshida K., Sanger J.M., Sanger J.W. Costameres are sites of force transmission to the substratum in adult rat cardiomyocytes. J Cell Biol 1992, 118(6):1411-1420.
39. Crosbie R.H., Heighway J., Venzke D.P., Lee J.C., Campbell K.P. Sarcospan: the 25kDa transmembrane component of the dystrophin-glycoprotein complex. J Biol Chem 1997, 272(50):31221-31224.
40. Ervasti J.M., Campbell K.P. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol 1993, 122(4):809-823.
41. Campbell K.P., Kahl S.D. Association of dystrophin and an integral membrane glycoprotein. Nature 1989, 338(6212):259-262.
42. Ervasti J.M., Kahl S.D., Campbell K.P. Purification of dystrophin from skeletal muscle. J Biol Chem 1991, 266(14):9161-9165.
43. Ervasti J.M., Ohlendieck K., Kahl S.D., Gaver M.G., Campbell K.P. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 1990, 345(6273):315-319.
44. Ervasti J.M., Campbell K.P. Membrane organization of the dystrophin-glycoprotein complex. Cell 1991, 66(6):1121-1131.
45. Yoshida M., Ozawa E. Glycoprotein complex anchoring dystrophin to sarcolemma. J Biochem 1990, 108(5):748-752.
46. Ervasti J.M., Campbell K.P. Dystrophin-associated glycoproteins: their possible roles in the pathogenesis of Duchenne muscular dystrophy. Mol Cell Biol Hum Dis Ser 1993, 3:139-166.
47. Holt K.H., Lim L.E., Straub V., et al. Functional rescue of the sarcoglycan complex in the Bio 14.6 hamster using δ-sarcoglycan gene transfer. Mol Cell 1998, 1:841-848.
48. Jung D., Yang B., Meyer J., Chamberlain J.S., Campbell K.P. Identification and characterization of the dystrophin anchoring site on beta-dystroglycan. J Biol Chem 1995, 270(45):27305-27310.
49. Rybakova I.N., Amann K.J., Ervasti J.M. A new model for the interaction of dystrophin with F-actin. J Cell Biol 1996, 135(3):661-672.
50. Rybakova I.N., Ervasti J.M. Dystrophin-glycoprotein complex is monomeric and stabilizes actin filaments in vitro through a lateral association. J Biol Chem 1997, 272(45):28771-28778.
51. Allamand V., Campbell K.P. Animal models for muscular dystrophy: valuable tools for the development of therapies. Hum Mol Genet 2000, 9(16):2459-2467.
52. Crosbie R.H., Lebakken C.S., Holt K.H., et al. Membrane targeting and stabilization of sarcospan is mediated by the sarcoglycan subcomplex. J Cell Biol 1999, 145(1):153-165.
53. Peter A.K., Miller G., Crosbie R.H. Disrupted mechanical stability of the dystrophin-glycoprotein complex causes severe muscular dystrophy in sarcospan transgenic mice. J Cell Sci 2007, 120(Pt 6):996-1008.
54. Towbin J.A., Hejtmancik J.F., Brink P., et al. X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation 1993, 87(6):1854-1865.
55. Hoffman E.P., Brown R.H., Kunkel L.M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987, 51:919-928.
56. Badorff C., Lee G.H., Lamphear B.J., et al. Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat Med 1999, 5(3):320-326.
57. Xiong D., Lee G.H., Badorff C., et al. Dystrophin deficiency markedly increases enterovirus-induced cardiomyopathy: a genetic predisposition to viral heart disease. Nat Med 2002, 8(8):872-877.
58. Guyon J.R., Kudryashova E., Potts A., et al. Calpain 3 cleaves filamin C and regulates its ability to interact with gamma- and delta-sarcoglycans. Muscle Nerve 2003, 28(4):472-483.
59. Luan X., Hong D., Zhang W., Wang Z., Yuan Y. A novel heterozygous deletion-insertion mutation (2695-2712 del/GTTTGT ins) in exon 18 of the filamin C gene causes filaminopathy in a large Chinese family. Neuromuscul Disord 2010, 20(6):390-396.
60. Shatunov A., Olive M., Odgerel Z., et al. In-frame deletion in the seventh immunoglobulin-like repeat of filamin C in a family with myofibrillar myopathy. Eur J Hum Genet 2009, 17(5):656-663.
61. Kono S., Nishio T., Takahashi Y., et al. Dominant-negative effects of a novel mutation in the filamin myopathy. Neurology 2010, 75(6):547-554.
62. Dalkilic I., Schienda J., Thompson T.G., Kunkel L.M. Loss of FilaminC (FLNc) results in severe defects in myogenesis and myotube structure. Mol Cell Biol 2006, 26(17):6522-6534.
63. Pardo J.V., Siliciano J.D., Craig S.W. Vinculin is a component of an extensive network of myofibril-sarcolemma attachment regions in cardiac muscle fibers. J Cell Biol 1983, 97(4):1081-1088.
64. Xu W., Baribault H., Adamson E.D. Vinculin knockout results in heart and brain defects during embryonic development. Development 1998, 125(2):327-337.
65. Zemljic-Harpf A.E., Ponrartana S., Avalos R.T., et al. Heterozygous inactivation of the vinculin gene predisposes to stress-induced cardiomyopathy. Am J Pathol 2004, 165(3):1033-1044.
66. Zemljic-Harpf A.E., Miller J.C., Henderson S.A., et al. Cardiac-myocyte-specific excision of the vinculin gene disrupts cellular junctions, causing sudden death or dilated cardiomyopathy. Mol Cell Biol 2007, 27(21):7522-7537.
67. Olson T.M., Illenberger S., Kishimoto N.Y., et al. Metavinculin mutations alter actin interaction in dilated cardiomyopathy. Circulation 2002, 105(4):431-437.
68. Hynes R.O. Integrins: bidirectional, allosteric signaling machines. Cell 2002, 110(6):673-687.
69. Gontier Y., Taivainen A., Fontao L., et al. The Z-disc proteins myotilin and FATZ-1 interact with each other and are connected to the sarcolemma via muscle-specific filamins. J Cell Sci 2005, 118(Pt 16):3739-3749.
70. Luo B.H., Carman C.V., Springer T.A. Structural basis of integrin regulation and signaling. Annu Rev Immunol 2007, 25:619-647.
71. Ginsberg M.H., Partridge A., Shattil S.J. Integrin regulation. Curr Opin Cell Biol 2005, 17(5):509-516.
72. Ross R.S., Pham C., Shai S.Y., et al. Beta1 integrins participate in the hypertrophic response of rat ventricular myocytes. Circ Res 1998, 82(11):1160-1172.
73. Valencik M.L., Keller R.S., Loftus J.C., McDonald J.A. A lethal perinatal cardiac phenotype resulting from altered integrin function in cardiomyocytes. J Card Fail 2002, 8(4):262-272.
74. Valencik M.L., Zhang D., Punske B., et al. Integrin activation in the heart: a link between electrical and contractile dysfunction?. Circ Res 2006, 99(12):1403-1410.
75. Zemljic-Harpf A., Manso A.M., Ross R.S. Vinculin and talin: focus on the myocardium. J Investig Med 2009, 57(8):849-855.
76. Stephens L.E., Sutherland A.E., Klimanskaya I.V., et al. Deletion of beta 1 integrins in mice results in inner cell mass failure and peri-implantation lethality. Genes Dev 1995, 9(15):1883-1895.
77. Fassler R., Meyer M. Consequences of lack of beta 1 integrin gene expression in mice. Genes Dev 1995, 9(15):1896-1908.
78. Shai S.Y., Harpf A.E., Babbitt C.J., et al. Cardiac myocyte-specific excision of the beta1 integrin gene results in myocardial fibrosis and cardiac failure. Circ Res 2002, 90(4):458-464.
79. Elsherif L., Huang M.S., Shai S.Y., et al. Combined deficiency of dystrophin and beta1 integrin in the cardiac myocyte causes myocardial dysfunction, fibrosis and calcification. Circ Res 2008, 102(9):1109-1117.
80. Legate K.R., Montanez E., Kudlacek O., Fassler R. ILK, PINCH and parvin: the tIPP of integrin signalling. Nat Rev Mol Cell Biol 2006, 7(1):20-31.
81. Sakai T., Li S., Docheva D., et al. Integrin-linked kinase (ILK) is required for polarizing the epiblast, cell adhesion, and controlling actin accumulation. Genes Dev 2003, 17(7):926-940.
82. White D.E., Coutu P., Shi Y.F., et al. Targeted ablation of ILK from the murine heart results in dilated cardiomyopathy and spontaneous heart failure. Genes Dev 2006, 20(17):2355-2360.
83. Lu H., Fedak P.W., Dai X., et al. Integrin-linked kinase expression is elevated in human cardiac hypertrophy and induces hypertrophy in transgenic mice. Circulation 2006, 114(21):2271-2279.
84. Liang X., Zhou Q., Li X., et al. PINCH1 plays an essential role in early murine embryonic development but is dispensable in ventricular cardiomyocytes. Mol Cell Biol 2005, 25(8):3056-3062.
85. Liang X., Sun Y., Schneider J., et al. Pinch1 is required for normal development of cranial and cardiac neural crest-derived structures. Circ Res 2007, 100(4):527-535.
86. Liang X., Sun Y., Ye M., et al. Targeted ablation of PINCH1 and PINCH2 from murine myocardium results in dilated cardiomyopathy and early postnatal lethality. Circulation 2009, 120(7):568-576.
87. Liang X., Sun Y., Chen J. Particularly interesting cysteine- and histidine-rich protein in cardiac development and remodeling. J Investig Med 2009, 57(8):842-848.
88. DiMichele L.A., Doherty J.T., Rojas M., et al. Myocyte-restricted focal adhesion kinase deletion attenuates pressure overload-induced hypertrophy. Circ Res 2006, 99(6):636-645.
89. Hakim Z.S., DiMichele L.A., Doherty J.T., et al. Conditional deletion of focal adhesion kinase leads to defects in ventricular septation and outflow tract alignment. Mol Cell Biol 2007, 27(15):5352-5364.
90. Hakim Z.S., DiMichele L.A., Rojas M., et al. FAK regulates cardiomyocyte survival following ischemia/reperfusion. J Mol Cell Cardiol 2009, 46(2):241-248.
91. Peng X., Wu X., Druso J.E., et al. Cardiac developmental defects and eccentric right ventricular hypertrophy in cardiomyocyte focal adhesion kinase (FAK) conditional knockout mice. Proc Natl Acad Sci USA 2008, 105(18):6638-6643.
92. Peng X., Kraus M.S., Wei H., et al. Inactivation of focal adhesion kinase in cardiomyocytes promotes eccentric cardiac hypertrophy and fibrosis in mice. J Clin Invest 2006, 116(1):217-227.
93. Shen T.L., Park A.Y., Alcaraz A., et al. Conditional knockout of focal adhesion kinase in endothelial cells reveals its role in angiogenesis and vascular development in late embryogenesis. J Cell Biol 2005, 169(6):941-952.
94. Peng X., Ueda H., Zhou H., et al. Overexpression of focal adhesion kinase in vascular endothelial cells promotes angiogenesis in transgenic mice. Cardiovasc Res 2004, 64(3):421-430.
95. Ilic D., Furuta Y., Kanazawa S., et al. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 1995, 377(6549):539-544.
96. Jani K., Schock F. Zasp is required for the assembly of functional integrin adhesion sites. J Cell Biol 2007, 179(7):1583-1597.
97. Rui Y., Bai J., Perrimon N. Sarcomere formation occurs by the assembly of multiple latent protein complexes. PLoS Genet 2010, 6(11):e1001208.